Drugs in pharmacology are classified using several overlapping systems, each designed to organize medications from a different angle. The two most fundamental are therapeutic classification (what condition the drug treats) and pharmacological classification (how the drug works in the body). Beyond these, drugs are also grouped by their chemical structure, their legal status, their receptor activity, and whether they’re derived from living organisms or built through chemistry. Understanding these systems helps make sense of why the same drug can appear in multiple categories at once.
Therapeutic Classification
Therapeutic classification groups drugs by the condition or symptom they treat. This is the most intuitive system and the one you’ll encounter most often outside a classroom. A drug prescribed to lower blood pressure falls under cardiovascular agents. One that fights bacterial infections is an antibacterial. One that manages seizures is an anticonvulsant.
The U.S. Pharmacopeia maintains a long list of therapeutic categories recognized by the FDA. Some of the most common include analgesics (pain relievers), antidepressants, antivirals, antifungals, antipsychotics, blood glucose regulators, respiratory tract agents, gastrointestinal agents, and anti-inflammatory agents. The full list runs to over 50 major categories, with many containing dozens of individual drugs. Therapeutic classification is practical because it matches how doctors think when choosing a treatment: they start with the problem, then look at which drugs address it.
The limitation is that drugs in the same therapeutic class can work through completely different biological pathways. Two medications both classified as “cardiovascular agents” might lower blood pressure in entirely unrelated ways, which matters when one causes side effects or doesn’t work for a particular patient.
Pharmacological Classification
Pharmacological classification sorts drugs by their mechanism of action, meaning what they actually do at a molecular level inside your body. This system answers the “how” rather than the “what for.” The FDA defines pharmacologic class using up to three attributes: mechanism of action, physiologic effect, and chemical structure.
For example, several drugs treat high blood pressure, but they do so through different mechanisms. Some relax blood vessel walls. Others reduce the volume of fluid in your bloodstream by increasing urine output. Still others slow the heart rate. Each of these represents a different pharmacological class, even though all the drugs share the same therapeutic category.
This classification is especially useful when a patient doesn’t respond well to one drug. A doctor can switch to a medication with a different mechanism of action rather than trying another drug that works the same way. It also helps predict side effects, since drugs that share a mechanism tend to share similar risks.
How Drugs Act on Receptors
A more granular layer of classification looks at how drugs interact with the body’s receptors, the protein structures on or inside cells that receive chemical signals. Drugs fall into several categories based on this interaction.
Full agonists bind to a receptor and activate it to produce the maximum response a system is capable of. They essentially mimic the body’s own chemical messengers. Partial agonists also bind and activate the receptor, but they produce a weaker, submaximal response even at their highest dose. This built-in ceiling can be a safety advantage in some situations.
Antagonists bind to receptors but produce no response at all. They block the receptor, preventing the body’s own chemicals (or other drugs) from activating it. Think of them as occupying a parking space without turning the engine on. This distinction between agonists and antagonists is one of the most important concepts in pharmacology because it explains why some drugs stimulate a process while others shut it down, even when both target the exact same receptor.
Chemical Structure Classification
Drugs can also be grouped by their molecular structure. Medications built from similar chemical backbones often share pharmacological properties, side effect profiles, and the way the body absorbs and breaks them down. This is why drug names within the same chemical class frequently share a common suffix. Drugs ending in “-olol” belong to one chemical family, while those ending in “-pril” belong to another.
Chemical classification is most relevant in drug development and in understanding cross-reactions. If you have an allergic reaction to one drug, your doctor may avoid prescribing others with a closely related chemical structure.
The ATC System Used Internationally
The World Health Organization maintains a standardized global system called the Anatomical Therapeutic Chemical (ATC) classification. It organizes drugs into a five-level hierarchy. The first level sorts drugs into 14 broad anatomical or pharmacological groups based on the organ system they target. The second level narrows to pharmacological or therapeutic subgroups. The third and fourth levels divide further into chemical, pharmacological, or therapeutic subgroups. The fifth and most specific level identifies the individual chemical substance.
This layered system is used primarily for drug utilization research and international health statistics. It gives researchers a common language when comparing medication use across countries. For everyday purposes, you’re unlikely to encounter ATC codes directly, but they’re the backbone of how global health organizations track prescribing patterns.
Prescription Status
One of the simplest classifications is whether a drug requires a prescription or is available over the counter (OTC). Prescription drugs need a doctor’s authorization because they carry risks that require professional oversight, whether from side effects, potential for misuse, or complexity of dosing. OTC drugs are considered safe enough for people to use based on label directions without medical supervision.
Some drugs shift between these categories over time. A medication may start as prescription-only and later become available OTC once enough safety data accumulates. This reclassification typically happens when regulators determine that the average person can self-diagnose the condition it treats and use the drug safely without a clinician’s guidance.
Controlled Substance Schedules
Drugs with potential for abuse or dependence are placed into one of five schedules by regulatory agencies like the U.S. Drug Enforcement Administration. Schedule I includes substances considered to have the highest abuse potential and no currently accepted medical use. Schedule V includes drugs with the lowest relative abuse potential. Schedules II through IV fall along a gradient between these extremes, with increasing restrictions on how they can be prescribed, dispensed, and refilled as the schedule number decreases.
This classification exists entirely separate from how a drug works pharmacologically. A Schedule II drug and a Schedule V drug could share the same mechanism of action but carry very different legal restrictions based on their abuse and dependence profiles.
Biologics Versus Small Molecule Drugs
A newer and increasingly important distinction is between small molecule drugs and biologics. Most drugs on the market today are small molecules, manufactured through chemical synthesis in a lab. These are the traditional tablets and capsules most people picture when they think of medication.
Biologics are larger, more complex molecules extracted from or produced by living organisms, such as bacteria, yeast, or animal cells. They include things like vaccines, certain cancer treatments, and drugs used for autoimmune conditions. The manufacturing process is fundamentally different and far more sensitive to production conditions, which is why biologics tend to be more expensive. This structural distinction affects everything from how the drug is stored and administered (many biologics must be injected rather than swallowed) to how generic versions are regulated.
Pregnancy Safety Classification
For decades, the FDA classified drugs into pregnancy risk categories labeled A, B, C, D, and X, with A considered safest and X the most dangerous for a developing fetus. This system was retired in June 2015 under the Pregnancy and Lactation Labeling Rule (PLLR) because the letter grades were frequently misinterpreted and oversimplified complex risk information.
The replacement system uses three narrative sections on drug labels: Pregnancy, Lactation, and Females and Males of Reproductive Potential. Instead of a single letter, each section provides a written summary of what’s actually known about the drug’s risks and benefits during pregnancy and breastfeeding. The goal is to give both patients and prescribers more nuanced, individualized information rather than a deceptively simple letter grade. You may still see the old A-through-X categories referenced in older materials, but they no longer appear on new prescription drug labels.